Virtus ETF Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-19,751
| Closed | -$2.25M | – | 453 |
|
|
2019
Q1 | $2.25M | Buy |
19,751
+4,520
| +30% | +$515K | 4.79% | 1 |
|
|
2018
Q4 | $596K | Buy |
15,231
+5,069
| +50% | +$198K | 0.1% | 45 |
|
|
2018
Q3 | $554K | Buy |
10,162
+685
| +7% | +$37.3K | 0.06% | 110 |
|
|
2018
Q2 | $784K | Sell |
9,477
-10,547
| -53% | -$873K | 0.69% | 41 |
|
|
2018
Q1 | $1.33M | Sell |
20,024
-1,172
| -6% | -$78K | 1.16% | 10 |
|
|
2017
Q4 | $1.09M | Buy |
21,196
+15,378
| +264% | +$791K | 1.37% | 8 |
|
|
2017
Q3 | $519K | Buy |
5,818
+266
| +5% | +$23.7K | 0.07% | 85 |
|
|
2017
Q2 | $332K | Buy |
5,552
+191
| +4% | +$11.4K | 0.05% | 96 |
|
|
2017
Q1 | $286K | Buy |
5,361
+514
| +11% | +$27.4K | 0.05% | 141 |
|
|
2016
Q4 | $242K | Sell |
4,847
-434
| -8% | -$21.7K | 0.07% | 152 |
|
|
2016
Q3 | $317K | Hold |
5,281
| – | – | 0.15% | 95 |
|
|
2016
Q2 | $270K | Buy |
5,281
+30
| +0.6% | +$1.53K | 0.2% | 71 |
|
|
2016
Q1 | $155K | Buy |
+5,251
| New | +$155K | 0.21% | 117 |
|